Editorial

Current Pharmaceutical Design

Volumn 11, Issue 21, 2005, Pages 2669-2670

  Tai, Kwok Keung ^a  

^a Parkinson's and Movement Disorder Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CHLORIDE CHANNEL; ION CHANNEL; LOCAL ANESTHETIC AGENT; POTASSIUM CHANNEL; POTASSIUM ION; SULFONYLUREA RECEPTOR; VANILLOID RECEPTOR 1;

APOPTOSIS; BINDING SITE; CELL ADHESION; CELL PROLIFERATION; DRUG RESEARCH; EDITORIAL; EPILEPSY; GENETIC CODE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MOLECULAR BIOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 22944463003     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612054546860     Document Type: Editorial

References (7)

1. Fozzard HA, Lee PJ, Lipkind GM. Mechanism of Local Anesthetic Drug Action on Voltage-Gated Sodium Channels. Curr Pharm Design 2005; 11(21): 2671-2686.
2. Suh Y-G, Oh U. Activation and Activators of TRPV1 and Their Pharmaceutical Implication. Curr Pharm Design 2005; 11(21): 2687-2698.
3. ATP Channels. Curr Pharm Design 2005; 11(21): 2699-2716.
4. Kim D. Physiology and Pharmacology of Two-Pore Domain Potassium Channels. Curr Pharm Design 2005; 11(21): 2717-2736.
5. Lerche H, Weber YG, Jurkat-Rott K, Lehmann-Horn F. Ion Channel Defects in Idiopathic Epilepsies. Curr Pharm Design 2005; 11(21): 2737-2752.
6. Suh KS, Yuspa SH. Intracellular Chloride Channels: Critical Mediators of Cell Viability and Potential Targets for Cancer Therapy. Curr Pharm Design 2005; 11(21): 2753-2764.
7. Schmitz C, Perraud A-L. The TRPM Cation Channels in the Immune Context. Curr Pharm Design 2005; 11(21): 2765-2778.